Your browser doesn't support javascript.
loading
Epigenetic Approaches to the Treatment of Renal Cell Cancer
Korean Journal of Urological Oncology ; : 78-90, 2020.
Artigo | WPRIM | ID: wpr-836787
ABSTRACT
To summarize the epigenetics in renal cell carcinoma (RCC) and discuss the potential use of epigenetic modifiersas RCC biomarkers and treatments. Pertinent articles available on PubMed and google scholar database pertainingto kidney cancer and epigenetics were reviewed. Metastatic RCC is one of the most difficult cancers to treat.Although RCC is commonly known to be caused by VHL mutations, it is not enough to understand the completepathophysiology of RCC. Epigenetic factors can play a fundamental role in the pathogenesis of RCC. Epigeneticregulators are classified as epigenetic writers, readers, and erasers according to their role. In this review, wediscuss the potential role of epigenetic regulators as a biomarker for RCC. We also review medications thattarget epigenetic enzymes and are currently tried in RCC therapy.
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Revista: Korean Journal of Urological Oncology Ano de publicação: 2020 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Revista: Korean Journal of Urological Oncology Ano de publicação: 2020 Tipo de documento: Artigo